Xiongwei Zhu Selected Research

Alzheimer Disease (Alzheimer's Disease)

08/2008	Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis.
08/2008	Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients.
02/2008	Alzheimer disease and the role of free radicals in the pathogenesis of the disease.
01/2008	Retinoblastoma Protein Phosphorylation at Multiple Sites is Associated with Neurofibrillary Pathology in Alzheimer Disease.
12/2007	Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.
10/2007	Iron: the Redox-active center of oxidative stress in Alzheimer disease.
09/2007	Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts.
06/2007	Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses.
02/2007	Prevention and treatment of Alzheimer disease and aging: antioxidants.
01/2007	Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease.
12/2006	Aberrant localization of importin alpha1 in hippocampal neurons in Alzheimer disease.
12/2006	Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?
07/2006	Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression".
03/2006	Presenilin mutation: a deadly first hit in Alzheimer disease. A commentary on "aging sensitizes towards ROS formation and lipid peroxidation in PS1M146L transgenic mice".
01/2006	Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer disease.
01/2006	Heme deficiency in Alzheimer's disease: a possible connection to porphyria.
01/2006	The fallacy of amyloid and cognition in Alzheimer's disease.
09/2005	Nanoparticle and other metal chelation therapeutics in Alzheimer disease.
06/2005	Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron.
06/2005	Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?
02/2005	Mitogen- and stress-activated protein kinase 1: convergence of the ERK and p38 pathways in Alzheimer's disease.
02/2005	Insulin signaling, diabetes mellitus and risk of Alzheimer disease.
08/2004	Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease.
07/2004	Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease.
06/2004	Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease.
04/2004	Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease.
04/2004	Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species.
03/2004	Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease.
01/2004	The role of metabotropic glutamate receptors in Alzheimer's disease.
05/2003	Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?
09/2002	The role of mitogen-activated protein kinase pathways in Alzheimer's disease.
09/2002	Differential regulation of glutamate receptors in Alzheimer's disease.
05/2002	Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?

Articles by Research Topic

Disease

33	Alzheimer Disease (Alzheimer's Disease) 08/2008 - 05/2002
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2006 - 10/2004
1	Dissociative Disorders (Fugue) 08/2008
1	Parkinson Disease (Parkinson's Disease) 01/2008
1	Tauopathies 01/2008
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2007
1	Porphyrias 01/2006
1	Diabetes Mellitus 02/2005
1	Wounds and Injuries (Trauma) 09/2002

Drug/Important Bio-Agent (IBA)

7	Amyloid (Amyloid Fibrils)IBA 12/2007 - 05/2002
4	IronIBA 10/2007 - 04/2004
2	GonadotropinsIBA 01/2006 - 08/2004
2	Heme (Haem)IBA 01/2006 - 10/2004
1	Dynamins (Dynamin)IBA 08/2008
1	AntigensIBA 08/2008
1	Free RadicalsIBA 02/2008
1	Leucine (L-Leucine)FDA Link 01/2008
1	alpha-SynucleinIBA 01/2008
1	Retinoblastoma ProteinIBA 01/2008
1	Phosphotransferases (Kinase)IBA 01/2008
1	Cysteine (L-Cysteine)FDA Link 09/2007
1	Thioctic Acid (Lipoic Acid)IBA 09/2007
1	AntioxidantsIBA 02/2007
1	IsoprostanesIBA 01/2007
1	TrichosanthinIBA 01/2007
1	karyopherin alpha 2IBA 12/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2006
1	PresenilinsIBA 03/2006
1	steroidogenic acute regulatory proteinIBA 01/2006
1	RNA (Ribonucleic Acid)IBA 01/2006
1	Ribosomal RNAIBA 06/2005
1	mitogen and stress-activated protein kinase 1IBA 02/2005
1	Insulin (Novolin)FDA Link 02/2005
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 10/2004
1	HormonesIBA 08/2004
1	Estrogens (Estrogen)FDA Link 08/2004
1	CopperIBA 07/2004
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2004
1	metabotropic glutamate receptor 2IBA 04/2004
1	Cyclin BIBA 03/2004
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2004
1	Histones (Histone)IBA 05/2003
1	Glutamic Acid (Glutamate)FDA Link 09/2002
1	Glutamate Receptors (Glutamate Receptor)IBA 09/2002
1	Protein Kinases (Protein Kinase)IBA 09/2002

Therapy/Procedure

1	Therapeutics 09/2005